Article
Molecular Screening for Cervical Cancer
2 Sept 2025
Abstract excerpt
Background/Objectives: Cervical cancer (CC), a highly prevalent female neoplasia, has been prevented through repeated cervicovaginal cytology, the so-called Pap test, across women’s lifespans. The now undebatable role of Human Papillomaviruses in the etiology of CC and the development of high-throughput automated molecular amplification diagnostic platforms is allowing for the replacement of the Pap test with HPV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
